These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 35659120)
1. Inclusion body myositis and associated diseases: an argument for shared immune pathologies. Nelke C; Kleefeld F; Preusse C; Ruck T; Stenzel W Acta Neuropathol Commun; 2022 Jun; 10(1):84. PubMed ID: 35659120 [TBL] [Abstract][Full Text] [Related]
2. Inclusion Body Myositis and Neoplasia: A Narrative Review. Damian L; Login CC; Solomon C; Belizna C; Encica S; Urian L; Jurcut C; Stancu B; Vulturar R Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806366 [TBL] [Abstract][Full Text] [Related]
3. Morphologic and Molecular Patterns of Polymyositis With Mitochondrial Pathology and Inclusion Body Myositis. Kleefeld F; Uruha A; Schänzer A; Nishimura A; Roos A; Schneider U; Goebel HH; Schuelke M; Hahn K; Preusse C; Stenzel W Neurology; 2022 Nov; 99(20):e2212-e2222. PubMed ID: 36195449 [TBL] [Abstract][Full Text] [Related]
4. Loss of TDP-43 function and rimmed vacuoles persist after T cell depletion in a xenograft model of sporadic inclusion body myositis. Britson KA; Ling JP; Braunstein KE; Montagne JM; Kastenschmidt JM; Wilson A; Ikenaga C; Tsao W; Pinal-Fernandez I; Russell KA; Reed N; Mozaffar T; Wagner KR; Ostrow LW; Corse AM; Mammen AL; Villalta SA; Larman HB; Wong PC; Lloyd TE Sci Transl Med; 2022 Jan; 14(628):eabi9196. PubMed ID: 35044790 [TBL] [Abstract][Full Text] [Related]
5. Shared blood and muscle CD8+ T-cell expansions in inclusion body myositis. Dimitri D; Benveniste O; Dubourg O; Maisonobe T; Eymard B; Amoura Z; Jean L; Tiev K; Piette JC; Klatzmann D; Herson S; Boyer O Brain; 2006 Apr; 129(Pt 4):986-95. PubMed ID: 16455793 [TBL] [Abstract][Full Text] [Related]
6. Senescent fibro-adipogenic progenitors are potential drivers of pathology in inclusion body myositis. Nelke C; Schroeter CB; Theissen L; Preusse C; Pawlitzki M; Räuber S; Dobelmann V; Cengiz D; Kleefeld F; Roos A; Schoser B; Brunn A; Neuen-Jacob E; Zschüntzsch J; Meuth SG; Stenzel W; Ruck T Acta Neuropathol; 2023 Nov; 146(5):725-745. PubMed ID: 37773216 [TBL] [Abstract][Full Text] [Related]
7. Cell type mapping of inflammatory muscle diseases highlights selective myofiber vulnerability in inclusion body myositis. Wischnewski S; Thäwel T; Ikenaga C; Kocharyan A; Lerma-Martin C; Zulji A; Rausch HW; Brenner D; Thomas L; Kutza M; Wick B; Trobisch T; Preusse C; Haeussler M; Leipe J; Ludolph A; Rosenbohm A; Hoke A; Platten M; Weishaupt JH; Sommer CJ; Stenzel W; Lloyd TE; Schirmer L Nat Aging; 2024 Jul; 4(7):969-983. PubMed ID: 38834884 [TBL] [Abstract][Full Text] [Related]
8. Uncovering the significance of expanded CD8 McLeish E; Sooda A; Slater N; Kachigunda B; Beer K; Paramalingam S; Lamont PJ; Chopra A; Mastaglia FL; Needham M; Coudert JD Front Immunol; 2023; 14():1153789. PubMed ID: 37063893 [TBL] [Abstract][Full Text] [Related]
9. Myositis-related autoantibody profile and clinical characteristics stratified by anti-cytosolic 5'-nucleotidase 1A status in connective tissue diseases. Diederichsen LP; Iversen LV; Nielsen CT; Jacobsen S; Hermansen ML; Witting N; Cortes R; Korsholm SS; Krogager ME; Friis T Muscle Nerve; 2023 Jul; 68(1):73-80. PubMed ID: 37177880 [TBL] [Abstract][Full Text] [Related]
10. Imaging With PET/CT of Diffuse CD8 T-Cell Infiltration of Skeletal Muscle in Patients With Inclusion Body Myositis. Quinn C; Moulton K; Farwell M; Le W; Wilson I; Goel N; McConathy J; Greenberg SA Neurology; 2023 Sep; 101(11):e1158-e1166. PubMed ID: 37487752 [TBL] [Abstract][Full Text] [Related]
20. Pathophysiological Mechanisms and Treatment of Dermatomyositis and Immune Mediated Necrotizing Myopathies: A Focused Review. Kamperman RG; van der Kooi AJ; de Visser M; Aronica E; Raaphorst J Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457124 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]